首页> 外文期刊>Schizophrenia research and treatment >Attitude towards Antipsychotic Medications in Patients Diagnosed with Schizophrenia: A Cross-Sectional Study at Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia
【24h】

Attitude towards Antipsychotic Medications in Patients Diagnosed with Schizophrenia: A Cross-Sectional Study at Amanuel Mental Specialized Hospital, Addis Ababa, Ethiopia

机译:患有精神分裂症患者抗精神病药的态度:埃塞俄比亚Adad Ababa Adamuel Mental专业医院横断面研究

获取原文
       

摘要

Background. Poor attitude towards antipsychotic drugs is high, and it is a factor for non-adherence to treatment. This increases the risk of relapse, associated healthcare utilization, and costs. This study aimed to assess attitude towards antipsychotic medication among patients with schizophrenia. Objectives. The aim of this institution based cross-sectional study was to assess attitude towards antipsychotic medications and associated factors among patients with schizophrenia who attend the outpatient clinics at Amanuel Mental Specialized Hospital, 2018. Methods. In a cross-sectional study, 393 schizophrenic patients from Amanuel Mental Specialized Hospital were recruited by a systematic random sampling technique. Drug Attitude Inventory (DAI-10) was used to assess attitude, experience, and belief about antipsychotics. Glasgow antipsychotic side effect scale modified version, positive and negative syndrome scale, and Birch wood’s insight scale for psychosis were the instruments used to assess the associated factors. Simple and multiple linear regression analysis models were fitted, and the adjusted unstandardized beta (β) coefficient at 95% confidence interval was used. Results. The mean score of attitude towards antipsychotic medications was 6.51 with standard deviation (SD) of 2.22. In multiple linear regression, positive symptoms (β= -0.07, 95% CI: (-0.09, -0.05)), negative symptoms (β= -0.04, 95% CI: (-0.06,-0.02)), shorter (≤5 years) duration of illness (β= -0.39, 95% CI: (-0.63, -0.15)), first generation antipsychotics (β = -0.35, 95% CI: (-0.55,-0.14)), having sedation (β= -0.28, 95% CI: (-0.52, -0.02)), and extra-pyramidal side effects (β= -0.34, 95% CI: (-0.59,-0.09)) were factors negatively associated with attitude towards antipsychotic medication treatment. Insight to illness (β= 0.24, 95% CI: (0.20, 0.27) was a factor positively associated with attitude towards antipsychotic medications. Conclusion. The result suggests that the mean score of participants’ attitude towards antipsychotic medications was good. Prevention of side effects particularly due to first generation antipsychotics is necessary.
机译:背景。对抗精神病药物的态度很高,并且是非依赖于治疗的因素。这增加了复发的风险,相关的医疗保健利用率和成本。本研究旨在评估精神分裂症患者抗精神病药的态度。目标。该机构基于横断面研究的目的是评估患有精神分裂症患者的抗精神病药药物和相关因素的态度,他们参加2018年苋菜心理专业医院的门诊诊所。方法。在一个横断面研究中,通过系统随机抽样技术招募了来自Amanuel精神专业医院的393名精神分裂症患者。药物态度库存(Dai-10)用于评估抗精神病学的态度,经验和信仰。格拉斯哥抗精神病副作用规模改造版,正负综合征规模,桦木木材的精神病症的洞察规模是用于评估相关因素的仪器。安装了简单的线性回归分析模型,使用了95%置信区间的调整后的非标准化β(β)系数。结果。抗精神病药态度的平均态度是6.51,标准偏差(SD)为2.22。在多元线性回归中,阳性症状(β= -0.07,95%CI:(-0.09,-0.05)),阴性症状(β= -0.04,95%CI :( -0.06,-0.02)),短(≤ 5年)疾病持续时间(β= -0.39,95%CI:(-0.63,-0.15)),第一代抗精神病药(β= -0.35,95%CI :( -0.55,-0.14)),具有镇静( β= -0.28,95%CI :( -0.52,-0.02))和超金字塔副作用(β= -0.34,95%CI:(-0.59,-0.09)是与对抗精神病态的态度负相关的因素药物治疗。疾病的洞察(β= 0.24,95%CI:(0.20,0.27)是与对抗精神病药的态度正相关的因素。结论。结果表明,参与者对抗精神病药态度的平均得分是好的。预防侧尤其是由于第一代抗精神病药是必要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号